Timing of implant-removal in late acute periprosthetic joint infection: A multicenter observational study.


Journal

The Journal of infection
ISSN: 1532-2742
Titre abrégé: J Infect
Pays: England
ID NLM: 7908424

Informations de publication

Date de publication:
09 2019
Historique:
received: 18 04 2019
revised: 21 06 2019
accepted: 05 07 2019
pubmed: 19 7 2019
medline: 11 7 2020
entrez: 19 7 2019
Statut: ppublish

Résumé

We evaluated the treatment outcome in late acute (LA) periprosthetic joint infections (PJI) treated with debridement and implant retention (DAIR) versus implant removal. In a large multicenter study, LA PJIs of the hip and knee were retrospectively evaluated. Failure was defined as: PJI related death, prosthesis removal or the need for suppressive antibiotic therapy. LA PJI was defined as acute symptoms <3 weeks in patients more than 3 months after the index surgery and with a history of normal joint function. 445 patients were included, comprising 340 cases treated with DAIR and 105 cases treated with implant removal (19% one-stage revision (n = 20), 74.3% two-stage revision (n = 78) and 6.7% definitive implant removal (n = 7). Overall failure in patients treated with DAIR was 45.0% (153/340) compared to 24.8% (26/105) for implant removal (p < 0.001). Difference in failure rate remained after 1:1 propensity-score matching. A preoperative CRIME80-score ≥3 (OR 2.9), PJI caused by S. aureus (OR 1.8) and implant retention (OR 3.1) were independent predictors for failure in the multivariate analysis. DAIR is a viable surgical treatment for most patients with LA PJI, but implant removal should be considered in a subset of patients, especially in those with a CRIME80-score ≥3.

Identifiants

pubmed: 31319141
pii: S0163-4453(19)30198-7
doi: 10.1016/j.jinf.2019.07.003
pii:
doi:

Substances chimiques

Biomarkers 0

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

199-205

Informations de copyright

Copyright © 2019 The British Infection Association. Published by Elsevier Ltd. All rights reserved.

Auteurs

Marjan Wouthuyzen-Bakker (M)

Department of Medical Microbiology and Infection Prevention, University of Groningen, University Medical Center Groningen, Hanzeplein 1, 9713 GZ, Groningen, the Netherlands. Electronic address: m.wouthuyzen-bakker@umcg.nl.

Marine Sebillotte (M)

Department of Infectious Diseases and Intensive Care Medicine, Rennes University Hospital, Rennes, France.

Jose Lomas (J)

Bone Infection Unit, Nuffield Orthopaedic Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, England.

Benjamin Kendrick (B)

Bone Infection Unit, Nuffield Orthopaedic Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, England.

Eva Benavent Palomares (EB)

Infectious Disease Service, IDIBELL-Hospital Universitari Bellvitge, Barcelona, Spain.

Oscar Murillo (O)

Infectious Disease Service, IDIBELL-Hospital Universitari Bellvitge, Barcelona, Spain.

Javad Parvizi (J)

Rothman Institute at Thomas Jefferson University Hospital, Philadelphia, United States.

Noam Shohat (N)

Rothman Institute at Thomas Jefferson University Hospital, Philadelphia, United States; Department of Orthopaedic Surgery, Tel Aviv University, Tel Aviv, Israel.

Javier Cobo Reinoso (JC)

Servicio de Enfermedades Infecciosas, Hospital Universitario Ramón y Cajal, IRYCIS, Madrid, Spain.

Rosa Escudero Sánchez (RE)

Servicio de Enfermedades Infecciosas, Hospital Universitario Ramón y Cajal, IRYCIS, Madrid, Spain.

Marta Fernandez-Sampedro (M)

Infectious Diseases Unit, Department of Medicine, Hospital Universitario Marques de Valdecilla-IDIVAL, Cantabria, Spain.

Eric Senneville (E)

Department of Infectious Diseases, University Hospital Gustave Dron Hospital, Tourcoing, France.

Kaisa Huotari (K)

Inflammation Center, Infectious Diseases, Peijas Hospital, Helsinki University Hospital and University of Helsinki, Finland.

José Maria Barbero Allende (JMB)

Department of Internal Medicine, Hospital Universitario Principe de Asturias, Madrid, Spain.

Antonio Blanco García (AB)

Department of Internal Medicine-Emergency, IIS-Fundación Jiménez Díaz, UAM, Av. Reyes Católicos 2, 28040 Madrid, Spain.

Jaime Lora-Tamayo (J)

Department of Internal Medicine, Hospital Universitario 12 de Octubre, Instituto de Investigación i+12, Madrid, Spain.

Matteo Carlo Ferrari (MC)

Department of Prosthetic Joint Replacement and Rehabilitation Center, Humanitas Research Hospital and Humanitas University, Milan, Italy.

Danguole Vaznaisiene (D)

Department of Infectious Diseases, Medical Academy, Lithuanian University of Health Sciences, Kaunas Clinical Hospital, Kaunas, Lithuania.

Erlangga Yusuf (E)

Department of Microbiology, Antwerp University Hospital (UZA), University of Antwerp, Edegem, Belgium.

Craig Aboltins (C)

The Department of Infectious Diseases, Northern Health, Melbourne, Australia; Northern Clinical School, The University of Melbourne, Melbourne, Australia.

Rihard Trebse (R)

Service for Bone Infections, Valdoltra Orthopaedic Hospital, Ankaran, Slovenia.

Mauro José Salles (MJ)

Santa Casa de São Paulo School of Medical Sciences, São Paulo, Brasil.

Natividad Benito (N)

Infectious Diseases Unit, Department of Internal Medicine, Hospital de la Santa Creu i Sant Pau, Institut d'Investigació Biomèdica Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Spain.

Andrea Vila (A)

Servicio de Infectología, Hospital Italiano de Mendoza, Mendoza, Argentina.

Maria Dolores Del Toro (MDD)

Unidad Clínica de Enfermedades Infecciosa y Microbiología, Universidad de Sevilla, Instituto de Biomedicina de Sevilla (IBIS), Sevilla, Spain.

Tobias Siegfried Kramer (TS)

Nationales Referenzzentrum für Surveillance von nosokomialen Infektionen am Institut für Hygiene und Umweltmedizin Charité-Universitätsmedizin, Berlin, Germany; LADR, GmbH MVZ, Neuruppin, Germany.

Sabine Petersdorf (S)

Institute of Medical Microbiology, Hospital Hygiene University Hospital, Heinrich-Heine-University. Düsseldorf, Germany.

Vicens Diaz-Brito (V)

Infectious Diseases Unit, Parc Sanitari Sant Joan de Deu, IDIBAPS, Sant Boi, Barcelona, Spain.

Zeliha Kocak Tufan (ZK)

Infectious Diseases and Clinical Microbiology Department, Ankara Yildirim Beyazit University, Ataturk Training & Research Hospital, Ankara, Turkey.

Marisa Sanchez (M)

Infectious Diseases Section, Internal Medicine Service, Hospital Italiano de Buenos Aires, Argentina.

Cédric Arvieux (C)

Department of Infectious Diseases and Intensive Care Medicine, Rennes University Hospital, Rennes, France; Great West Reference centers for Complex Bone and Joint Infections (CRIOGO), France.

Alex Soriano (A)

Service of Infectious Diseases, Hospital Clínic, University of Barcelona, Barcelona, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH